SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-030875
Filing Date
2024-08-09
Accepted
2024-08-09 08:10:34
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1055402
2 ex31-1.htm EX-31.1 17785
3 ex31-2.htm EX-31.2 10368
4 ex32-1.htm EX-32.1 8413
5 ex32-2.htm EX-32.2 8401
  Complete submission text file 0001493152-24-030875.txt   6542025

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20240630.xsd EX-101.SCH 46887
7 XBRL CALCULATION FILE nrxs-20240630_cal.xml EX-101.CAL 55378
8 XBRL DEFINITION FILE nrxs-20240630_def.xml EX-101.DEF 254364
9 XBRL LABEL FILE nrxs-20240630_lab.xml EX-101.LAB 436403
10 XBRL PRESENTATION FILE nrxs-20240630_pre.xml EX-101.PRE 374956
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 959403
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41775 | Film No.: 241190468
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)